类别 :
公司分析 作者:
坚石 2012-02-22
序号上市公司持股比例 复星拥有市值投资成本
公司名股本 股价(人民币)市值
1滨化股份66,00017.871,179,4207.50%88,45714,535
2羚锐制药20,07213.13263,5450.59%1,555219
3海翔药业16,05024.55394,0283.72%14,6581,692
4汉森制药14,80023.12342,17614.86%50,8474,860
5水晶光电11,56536.79425,4769.90%42,1221,865
6东富龙科技16,00043.85701,600.007.50%52,6204,000
7金城医化12,10021.42259,182.0014.88%38,5665,200
8佰利联9,400124.751,172,650.0010.64%124,7705,300
9迪安诊断5,11038.15194,946.5010.57%20,6063,214
10民生银行5.623,2603,004
11西安隆基硅材料13,800
12青岛亨达11,853
13安徽山河药辅2,352
14颈复康12,000
15持有国内A股市值小计437,46083,894
16国药控股240,26220.44,901,34532%1,570,881
17
18先声药业#DIV/0!5,79614,327
19东瑞制药191,1462.16412,8761.53%6,31710,778
20中生北控13,1302.9738,99623.83%9,2936,463
21持有港股市值21,40625,105
22美中互利19.16%30,024
23同济堂32.10%18,591
24持有国外股市值
25天药股份54,3009.33506,619.0011.71%59,312
26利尔化学20,24415.38311,352.724.82%15,021
27中环股份72,42421.231,537,561.524.07%62,617
28间接持股市值136,950
29合计2,166,69827,171
注：1、利尔化学由中通投资持股25.73%，天津药业持有中通投资75%股份，复星医药持有天津药业25%股份
2、中环股份由天津药业持有16.29%股份
